Log in to save to my catalogue

In Silico Repurposed Drugs against Monkeypox Virus

In Silico Repurposed Drugs against Monkeypox Virus

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_1c3d3a4899ee4d5b8375c883f58da84c

In Silico Repurposed Drugs against Monkeypox Virus

About this item

Full title

In Silico Repurposed Drugs against Monkeypox Virus

Publisher

Switzerland: MDPI AG

Journal title

Molecules (Basel, Switzerland), 2022-08, Vol.27 (16), p.5277

Language

English

Formats

Publication information

Publisher

Switzerland: MDPI AG

More information

Scope and Contents

Contents

Monkeypox is an emerging epidemic of concern. The disease is caused by the monkeypox virus and an increasing global incidence with a 2022 outbreak that has spread to Europe amid the COVID-19 pandemic. The new outbreak is associated with novel, previously undiscovered mutations and variants. Currently, the US Food and Drug Administration (FDA) appro...

Alternative Titles

Full title

In Silico Repurposed Drugs against Monkeypox Virus

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_1c3d3a4899ee4d5b8375c883f58da84c

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_1c3d3a4899ee4d5b8375c883f58da84c

Other Identifiers

ISSN

1420-3049

E-ISSN

1420-3049

DOI

10.3390/molecules27165277

How to access this item